Immunomedics Inc - Company Profile
Powered by 
All the data and insights you need on Immunomedics Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Immunomedics Inc Strategy Report
- Understand Immunomedics Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Immunomedics Catalyst Calendar
Proactively evaluate Immunomedics Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.
A sample of Immunomedics Catalyst Calendar data
| Event Date | Event Type | Company Name | Ticker Symbol | Drug Name | Therapy Area | Indication | Source Type |
|---|---|---|---|---|---|---|---|
| 01 Jun 2020 | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Lorem |
| 01 Jun 2020 | Phase III Trial Initiation | Gilead Sciences Inc; Immunomedics Inc | GILD | sacituzumab govitecan | Oncology | Metastatic Cancer; Solid Tumor | Clinical Trial Registry |
| 01 Apr 2020 | Phase III Trial Completion | Gilead Sciences Inc; Immunomedics Inc; PPD Inc | GILD | sacituzumab govitecan | Oncology | Breast Cancer; Metastatic Breast Cancer; Triple-Negative Breast Cancer (TNBC) | Company Reports |
| 31 Mar 2020 | Regulatory Approval (US) | Immunomedics Inc | - | sacituzumab govitecan | Oncology | Triple-Negative Breast Cancer (TNBC) | Investment Bank Report |
Feature
Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.
Benefit
Access:
- Trial Events for trials conducted globally by a company, university, institute or CRO: Trial Initiation, Trial Completion, Trial Results
- Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
- Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)
Value
Proactively evaluate companies and catalyst impacts
Stay ahead of the competition & improve corporate planning
Bolster business development with timely opportunities
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer